Literature DB >> 16407379

Can modulating corticotropin releasing hormone receptors alter visceral sensitivity?

S Fukudo1, K Saito, Y Sagami, M Kanazawa.   

Abstract

Activation of corticotropin releasing hormone (CRH) receptor 2 (CRH-R2) reduces visceral sensitivity induced by colorectal distension in conscious rats. This finding is relevant to the increased interest in the potential use of therapeutic agents that act on CRH receptors in the treatment of irritable bowel syndrome.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16407379      PMCID： PMC1856495          DOI： 10.1136/gut.2005.070888

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


  30 in total

Review 1.  Role of peripheral CRF signalling pathways in stress-related alterations of gut motility and mucosal function.

Authors:  Y Taché; M H Perdue
Journal:  Neurogastroenterol Motil       Date:  2004-04       Impact factor: 3.598

2.  Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor.

Authors:  S Y Hsu; A J Hsueh
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

3.  Urocortin and corticotropin-releasing factor receptor expression in the human colonic mucosa.

Authors:  Y Muramatsu; K Fukushima; K Iino; K Totsune; K Takahashi; T Suzuki; G Hirasawa; J Takeyama; M Ito; M Nose; A Tashiro; M Hongo; Y Oki; H Nagura; H Sasano
Journal:  Peptides       Date:  2000-12       Impact factor: 3.750

4.  Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.

Authors:  T L Bale; A Contarino; G W Smith; R Chan; L H Gold; P E Sawchenko; G F Koob; W W Vale; K F Lee
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

5.  Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2.

Authors:  T Kishimoto; J Radulovic; M Radulovic; C R Lin; C Schrick; F Hooshmand; O Hermanson; M G Rosenfeld; J Spiess
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

Review 6.  Experience with anxiety and depression treatment studies: implications for designing irritable bowel syndrome clinical trials.

Authors:  R B Lydiard; S A Falsetti
Journal:  Am J Med       Date:  1999-11-08       Impact factor: 4.965

7.  Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats.

Authors:  C Maillot; M Million; J Y Wei; A Gauthier; Y Taché
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

8.  CRF2 receptor activation prevents colorectal distension induced visceral pain and spinal ERK1/2 phosphorylation in rats.

Authors:  M Million; L Wang; Y Wang; D W Adelson; P-Q Yuan; C Maillot; S V Coutinho; J A Mcroberts; A Bayati; H Mattsson; V Wu; J-Y Wei; J Rivier; W Vale; E A Mayer; Y Taché
Journal:  Gut       Date:  2005-06-28       Impact factor: 23.059

9.  Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome.

Authors:  Y Sagami; Y Shimada; J Tayama; T Nomura; M Satake; Y Endo; T Shoji; K Karahashi; M Hongo; S Fukudo
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

10.  Corticotropin releasing factor receptor antagonists: potential future therapy in gastroenterology?

Authors:  Y Taché
Journal:  Gut       Date:  2004-07       Impact factor: 23.059
View more
  10 in total

Review 1.  Sex and gender in irritable bowel syndrome.

Authors:  Shin Fukudo
Journal:  J Gastroenterol       Date:  2006-06       Impact factor: 7.527

Review 2.  Factors influencing functional abdominal pain in children.

Authors:  Ashis V Barad; Miguel Saps
Journal:  Curr Gastroenterol Rep       Date:  2008-06

3.  Suspended moxibustion relieves chronic visceral hyperalgesia and decreases hypothalamic corticotropin-releasing hormone levels.

Authors:  En-Hua Zhou; Xiao-Mei Wang; Guang-Hong Ding; Huan-Gan Wu; Li Qi; Hui-Rong Liu; Shu-Jing Zhang
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

Review 4.  Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation.

Authors:  Shin Fukudo
Journal:  J Gastroenterol       Date:  2007-01       Impact factor: 7.527

Review 5.  Irritable bowel syndrome: emerging paradigm in pathophysiology.

Authors:  Yoo Jin Lee; Kyung Sik Park
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

6.  Immunolocalization of corticotropin-releasing hormone (CRH) and its receptors (CRHR1 and CRHR2) in human endometrial carcinoma: CRHR1 as a potent prognostic factor.

Authors:  Naoko Sato; Kiyoshi Takagi; Takashi Suzuki; Yasuhiro Miki; Sota Tanaka; Satoru Nagase; Hitoshi Warita; Shin Fukudo; Fumiko Sato; Hironobu Sasano; Kiyoshi Ito
Journal:  Int J Gynecol Cancer       Date:  2014-11       Impact factor: 3.437

7.  Inhibitory effect of the Kampo medicinal formula Yokukansan on acute stress-induced defecation in rats.

Authors:  Yasuaki Kanada; Ayami Katayama; Hideshi Ikemoto; Kana Takahashi; Mana Tsukada; Akio Nakamura; Shogo Ishino; Tadashi Hisamitsu; Masataka Sunagawa
Journal:  Neuropsychiatr Dis Treat       Date:  2018-04-06       Impact factor: 2.570

8.  Relationship between sympathoadrenal and pituitary-adrenal response during colorectal distention in the presence of corticotropin-releasing hormone in patients with irritable bowel syndrome and healthy controls.

Authors:  Yukari Tanaka; Motoyori Kanazawa; Michiko Kano; Manabu Tashiro; Shin Fukudo
Journal:  PLoS One       Date:  2018-07-06       Impact factor: 3.240

9.  Gastrointestinal specific anxiety in irritable bowel syndrome: validation of the Japanese version of the visceral sensitivity index for university students.

Authors:  Tatsuo Saigo; Jun Tayama; Toyohiro Hamaguchi; Naoki Nakaya; Tadaaki Tomiie; Peter J Bernick; Motoyori Kanazawa; Jennifer S Labus; Bruce D Naliboff; Susumu Shirabe; Shin Fukudo
Journal:  Biopsychosoc Med       Date:  2014-03-21

10.  Differential Activation in Amygdala and Plasma Noradrenaline during Colorectal Distention by Administration of Corticotropin-Releasing Hormone between Healthy Individuals and Patients with Irritable Bowel Syndrome.

Authors:  Yukari Tanaka; Motoyori Kanazawa; Michiko Kano; Joe Morishita; Toyohiro Hamaguchi; Lukas Van Oudenhove; Huynh Giao Ly; Patrick Dupont; Jan Tack; Takuhiro Yamaguchi; Kazuhiko Yanai; Manabu Tashiro; Shin Fukudo
Journal:  PLoS One       Date:  2016-07-22       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.